Tissue Staining is a vital technique in histology and pathology, involving the application of dyes or chemicals to biological tissues to enhance their visibility under a microscope. Staining allows for the differentiation of cellular structures, identification of specific tissue components, and the visualization of pathological changes. Hematoxylin and eosin (H&E) staining is a widely used combination that imparts color to cell nuclei (blue) and cytoplasm (pink), aiding in the overall characterization of tissues. Specialized stains target specific cellular elements, such as periodic acid-Schiff (PAS) stain for glycogen, Masson's trichrome for collagen, or immunohistochemical stains for proteins. Immunohistochemistry involves the use of antibodies to detect specific antigens within tissues, offering insights into protein expression and localization. Fluorescent dyes enable visualization of specific molecules or structures, providing detailed information about cellular function. Tissue staining is essential in diagnosing diseases, evaluating tissue health, and understanding physiological processes. Digital pathology and image analysis technologies enhance the quantification and standardization of staining results. Advances in staining techniques continue to contribute to our understanding of complex biological processes, aiding medical research, diagnostics, and the development of targeted therapies.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States